Sachin A. Shah, PharmD


Rimonabant: A novel CB1 receptor antagonist for the treatment of obesity

November 01, 2006

Obesity is on the rise in the United States, with 60.5% of the adult population overweight and 23.9% obese as of 2005. Up to 10% of an industrialized country's healthcare budget often can be spent on obesity and associated comorbidities.